tldrdaily.news logo
Tag

Antibody Drug

All articles tagged with #antibody drug

health2 years ago

RSV Cases Rise as Vital Baby Drug Faces Shortage, CDC Warns

The Centers for Disease Control and Prevention (CDC) has issued an alert to doctors about a limited availability of a newly approved antibody drug, Beyfortus, used to prevent respiratory syncytial virus (RSV) infection in infants. RSV cases are increasing as cold and flu season begins, making it the most commonly identified respiratory virus causing disease in children. The highest dosage of Beyfortus, 100 milligrams, is in short supply, prompting the CDC to advise doctors to prioritize infants at the highest risk. Drugmaker Sanofi stated that demand for the drug has been higher than anticipated. Another option to prevent RSV infections in infants is the antibody drug Synagis, approved for high-risk infants during RSV season. The FDA also approved the RSV vaccine Abrysvo for use in pregnant women to protect their babies in their first six months of life.

via NBC News|
#antibody-drug#cdc#drug-shortage
health2 years ago

"Revolutionary Drug in Clinical Trials: Regrowing Teeth Becomes a Reality"

Japanese pharmaceutical company Toregem Biopharma has developed an antibody drug that inhibits a gene responsible for suppressing tooth growth, potentially allowing for the regrowth of human teeth. The company plans to begin human clinical trials in July 2024 and aims to bring the drug to market by 2030. Animal research has shown promising results, and the company hopes to help children with genetic disorders and adults who have lost teeth due to cavities. The drug could offer a non-invasive alternative to implants and dentures, leveraging the body's own abilities for tooth regrowth.

via Futurism|
#antibody-drug#clinical-trials#dental-health
health2 years ago

FDA advisors recommend RSV antibody drug for infants.

A panel of FDA advisers has recommended the approval of a new antibody drug called nirsevimab to protect infants from serious lung illnesses caused by respiratory syncytial virus (RSV). The drug would offer babies protection from the virus in their first RSV seasons with a single shot and would be more affordable and widely available than the existing preventive drug. RSV is a viral infection that puts tens of thousands of young children in the hospital each year, making it the leading cause of hospitalization among infants in the U.S. The FDA is expected to decide on the drug's approval in the third quarter of 2023.

via NPR|
#antibody-drug#fda#health
health2 years ago

AstraZeneca Develops COVID Drug Effective Against All Variants.

AstraZeneca's experimental drug, AZD3152, could be available by the end of the year, pending results from the "Supernova" trial, which is testing the drug's ability to prevent symptomatic infection in immunocompromised individuals. The drug has shown promising results in lab research, neutralizing all known variants of concern to date, including the latest Arcturus variant. AZD3152 is based on a different antibody than its predecessor, Evusheld, and is designed to have broader variant coverage for six months. The drug could benefit the 2% of the population who cannot mount an effective immune response from COVID-19 vaccines. Federal officials have expressed concern over the lack of options for immunocompromised Americans, and the Biden administration has recently announced a new infusion of federal funding for the development of new vaccines and antibody drugs.

via CBS News|
#antibody-drug#astrazeneca#azd3152